Cannabis Science Awaits Full Biopsy Report As Newest Series of Photos Shows Cancer Lesion Evidently Completely Killed & Hair ...
February 07 2012 - 04:59AM
Business Wire
Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech
company developing pharmaceutical cannabis (marijuana) products, is
pleased to present the newest set of photographs showing evidence
that the cancer cells appear to have been killed over the course of
treatment from the 2nd self-administering cancer patient suffering
from squamous cell carcinoma on her arm.
Later this month, the patient expects to have a full biopsy
report on the now apparently healthy skin that has replaced the
tumor. The tumor appears to have been expelled from below the
surface, killed, and now fully healed. In these latest photos, not
only does the lesion seem to have completely disappeared, but also
hair is re-growing on the new healthy skin.
Cannabis Science first reported this patient in a news release
dated January 19, 2012, this current series of photos show the
disappearance of a biopsied squamous cell tumor after self-
administration of topical cannabis extracts over a 3-month
period.
You can view these photos on the Cannabis Science website
www.cannabisscience.com and click the button “View Images of 2nd
Self-Medicated Patient & The Apparent Success”
Cannabis Science is a patient oriented company. As such, we work
closely with a number of patients suffering from a variety of
illnesses including various cancers. Because of the global impact
that cancer has on so many people, and the often-poor treatment
outcome for patients, we have focused on cannabis extract-based
treatment options for cancer. Cannabis Science provides the
scientific foundation, and for some the formulations for numerous
patients, suffering from a large variety of cancers, to make
informed decisions to treat themselves with cannabis extracts
properties, to treat disease and the symptoms of disease, as well
as for general health maintenance.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical
grade medical marijuana research and development. The second
formulations will address the needs of patients choosing to use
concentrated cannabis extracts to treat their ailments. Eventually,
all Americans will have access to a safe and effective FDA approved
medicine regardless of which state they live in. To maintain that
marijuana is a dangerous, addictive drug with no medical value is
scientifically absurd. Cannabis medicines, with no effective lethal
dose, are far safer than aspirin, acetaminophen, and most other OTC
drugs that kill thousands of Americans every year. The Company
works with world authorities on phytocannabinoid science targeting
critical illnesses, and adheres to scientific methodologies to
develop, produce and commercialize phytocannabinoid-based
pharmaceutical products. In sum, we are dedicated to the creation
of cannabis-based medicines, both with and without psychoactive
properties, to treat disease and the symptoms of disease, as well
as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. Cannabis Science, Inc. does not undertake any duty nor does
it intend to update the results of these forward-looking
statements.